RhumbLine Advisers’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$567K Buy
136,539
+3,000
+2% +$12.2K ﹤0.01% 2538
2025
Q4
$863K Sell
133,539
-931
-0.7% -$5.8K ﹤0.01% 2317
2025
Q3
$752K Sell
134,470
-6,402
-5% -$27.7K ﹤0.01% 2416
2025
Q2
$466K Buy
140,872
+36,509
+35% +$105K ﹤0.01% 2723
2025
Q1
$303K Sell
104,363
-2,594
-2% -$7.85K ﹤0.01% 2885
2024
Q4
$381K Buy
106,957
+3,259
+3% +$15K ﹤0.01% 2835
2024
Q3
$516K Buy
103,698
+5,861
+6% +$22.8K ﹤0.01% 2676
2024
Q2
$254K Buy
+97,837
New +$327K ﹤0.01% 3090
2021
Q2
Sell
-18,815
Closed -$98K 2987
2021
Q1
$98K Sell
18,815
-925
-5% -$4.92K ﹤0.01% 2935
2020
Q4
$106K Buy
19,740
+2,960
+18% +$17.7K ﹤0.01% 2963
2020
Q3
$81K Sell
16,780
-260
-2% -$1.7K ﹤0.01% 2905
2020
Q2
$83K Buy
+17,040
New +$78.4K ﹤0.01% 2990

Other funds holding AQST